百奥赛图科创板IPO:一百七十余项财务数据呈现规律性变化

估值之家
Aug 07

CRO是在医药研发过程中受医药公司或其他医药研发机构委托,进行部分或全部医学试验,以获取商业性报酬的组织或机构。主要分为临床前CRO与临床CRO两类,前者专注于化合物发现、药代动力学及毒理学研究等临床前阶段服务;后者覆盖I至IV期临床试验、数据管理及上市后监测等临床阶段服务。当然业内并不乏提供覆盖临床前及临床全阶段的一站式研发服务的CRO企业。百奥赛图(北京)医药科技股份有限公司(本文简称:“...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10